BRAF and melanoma: Though there are several therapeutic approaches used in the treatment of melanoma, including targeting PD-L and BRAF kinase with V600E or V600D mutation, there is still no effective drug targeting all subtypes of skin melanoma nor ocular or mucosal melanoma or primary melanoma found in other organs [10,11].